~~<i id='11F0E19214'><strike id='11F0E19214'><tt id='11F0E19214'><pre id='11F0E19214'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：fashion 2025-09-29 13:46:29 - browse：66759

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： What American doctors can learn from their Israeli counterparts

Wikipedia

leisure time

hotspot

focus

entertainment

hotspot

Dr.MonicaBertagnollispeaksduringavisitfromfirstladyJillBidentotheUniversityofCaliforniaSanFranciscoH

WSS

Advances in CAR

Advances in CAR

What drug price negotiations mean for Medicare Part D

Snackable artificial intelligence, expert AI, and the pharma industry

CommonSpirit Health keeps growing, even as it loses money

Humana sues Biden admin over Medicare Advantage audit rule

entertainment

explore

Wikipedia

Drug repurposing or repositioning? The language matters

It's been 20 years since Dolly the sheep. Where's my clone?

Heart attack and stroke risk calculators need revising

It's been 20 years since Dolly the sheep. Where's my clone?

Novavax promises a turnaround & Lilly roils the obesity market

Trump surgeon general acknowledges mistakes during Covid

After affirmative action ruling, medical educators look to 'holistic review'

Medicaid rebukes states for mistakenly disenrolling children

Wildfire smoke exposes gaps in outdoor worker protections

Senate HELP committee spars over health care workforce policies

leisure time

A rare thyroid diagnosis led to unexpected, all

What drug price negotiations mean for Medicare Part D

STAT Virtual Event: Putting AI to the Test

Senate HELP committee spars over health care workforce policies

Drug for rare kidney disease narrowly misses mark in clinical trial

FDA panel to weigh approval of NurOwn, controversial ALS drug

hotspot

focus

entertainment

hotspot